azibiot neo 40 mg/ml prášok na perorálnu suspenziu
krka, d.d., novo mesto, slovinsko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
azibiot neo 20 mg/ml prášok na perorálnu suspenziu
krka, d.d., novo mesto, slovinsko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
enstilar 50 mikrogramov/g + 0,5 mg/g
leo pharma a/s , dánsko - kalcipotriol, kombinácie - 46 - dermatologica
bisoprolol medreg 10 mg
medreg s.r.o., Česká republika - bisoprolol - 41 - cardiaca
bisoprolol medreg 5 mg
medreg s.r.o., Česká republika - bisoprolol - 41 - cardiaca
bisoprolol medreg 2,5 mg
medreg s.r.o., Česká republika - bisoprolol - 41 - cardiaca
ilumetri
almirall s.a - tildrakizumab - svrab - imunosupresívami, interleukín inhibítory, - ilumetri je indikovaný na liečbu dospelých so stredne ťažkým až ťažkým lupienky, ktorí sa uchádzajú o systémová terapia.
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresíva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
byfavo
paion deutschland gmbh - remimazolam besilate - vedomie sedácie - psycholeptika - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.
wegovy
novo nordisk a/s - semaglutide - obesity; overweight - prípravky proti obezite, okrem diétne výrobky - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.